Literature DB >> 12075079

Mixed patterns of transmission of human herpesvirus-8 (Kaposi's sarcoma-associated herpesvirus) in Malawian families.

Rachelle D Cook1,2, Tim A Hodgson2, Alastair C W Waugh2, Elizabeth M Molyneux3, Eric Borgstein3, A Sherry3, Chong Gee Teo1, Stephen R Porter2.   

Abstract

To study transmission patterns of human herpesvirus-8 (HHV-8) (Kaposi's sarcoma-associated herpesvirus) in families in Malawi, nucleotide sequences derived from two hypervariable loci of the HHV-8 genome, the V1 and V2 regions of open reading frame K1 (K1/V1 and K1/V2, respectively), were amplified from blood and mouth rinse samples of 22 patients with treated and untreated Kaposi's sarcoma (KS) and their first-degree relatives (n=67). In patients with KS, vincristine therapy was significantly associated with non-detectability of circulating, but not oral, K1/V1 DNA. Intra-familial K1/V1 phylogenetic comparisons of eight families were possible. Both identical and non-identical sequences were observed between family members, suggesting transmission of HHV-8 along both intra- and extra-familial transmission routes.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12075079     DOI: 10.1099/0022-1317-83-7-1613

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  10 in total

1.  Model-based inference of recombination hotspots in a highly variable oncogene [corrected].

Authors:  G Greenspan; D Geiger; F Gotch; M Bower; S Patterson; M Nelson; B Gazzard; J Stebbing
Journal:  J Mol Evol       Date:  2004-03       Impact factor: 2.395

2.  Confirming shedding of human herpesvirus 8 in urine from infected patients in Brazil.

Authors:  Elizabeth Santos-Fortuna; Adele Caterino-de-Araujo
Journal:  J Clin Microbiol       Date:  2005-02       Impact factor: 5.948

3.  Characterization of the Kaposi's sarcoma-associated herpesvirus K1 signalosome.

Authors:  Bok-Soo Lee; Sun-Hwa Lee; Pinghui Feng; Heesoon Chang; Nam-Hyuk Cho; Jae U Jung
Journal:  J Virol       Date:  2005-10       Impact factor: 5.103

4.  Genotypic profile of human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus) in urine.

Authors:  M M Beyari; T A Hodgson; W Kondowe; E M Molyneux; C M Scully; S R Porter; C G Teo
Journal:  J Clin Microbiol       Date:  2004-07       Impact factor: 5.948

5.  Mortality among HIV-1- and human herpesvirus type 8-affected mother-infant pairs in Zambia.

Authors:  Janet Wojcicki; Mulindi Mwanahamuntu; Veenu Minhas; Boris Djokic; Chipepo Kankasa; Winslow Klaskala; Brad Brayfield; Saul Phiri; Charles Wood; Charles D Mitchell
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-09       Impact factor: 4.254

6.  Human herpesvirus-8 infection and oral shedding in Amerindian and non-Amerindian populations in the Brazilian Amazon region.

Authors:  Vanda A U F de Souza; Laura M Sumita; Maria-Claudia Nascimento; Juliane Oliveira; Melissa Mascheretti; Mariana Quiroga; Wilton S Freire; Adriana Tateno; Marcos Boulos; Philippe Mayaud; Claudio S Pannuti
Journal:  J Infect Dis       Date:  2007-08-06       Impact factor: 5.226

7.  Structural analysis of the Kaposi's sarcoma-associated herpesvirus K1 protein.

Authors:  Bok-Soo Lee; Michelle Connole; Zuoquin Tang; Nancy L Harris; Jae U Jung
Journal:  J Virol       Date:  2003-07       Impact factor: 5.103

Review 8.  Reflections on the interpretation of heterogeneity and strain differences based on very limited PCR sequence data from Kaposi's sarcoma-associated herpesvirus genomes.

Authors:  Jian-Chao Zong; Ravit Arav-Boger; Donald J Alcendor; Gary S Hayward
Journal:  J Clin Virol       Date:  2007-08-14       Impact factor: 3.168

9.  Wild-type Kaposi's sarcoma-associated herpesvirus isolated from the oropharynx of immune-competent individuals has tropism for cultured oral epithelial cells.

Authors:  Karen M Duus; Vivian Lentchitsky; Timothy Wagenaar; Charles Grose; Jennifer Webster-Cyriaque
Journal:  J Virol       Date:  2004-04       Impact factor: 5.103

Review 10.  KSHV (HHV8) vaccine: promises and potential pitfalls for a new anti-cancer vaccine.

Authors:  Corey Casper; Lawrence Corey; Jeffrey I Cohen; Blossom Damania; Anne A Gershon; David C Kaslow; Laurie T Krug; Jeffrey Martin; Sam M Mbulaiteye; Edward S Mocarski; Patrick S Moore; Javier Gordon Ogembo; Warren Phipps; Denise Whitby; Charles Wood
Journal:  NPJ Vaccines       Date:  2022-09-20       Impact factor: 9.399

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.